Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MELIA: Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment in AEH or Early Endometrial Cancer
NCT07781150Phase 2Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Nov 2026
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
A Phase 2 trial of mazdutide in Atypical endometrial hyperplasia (AEH), endometrioid endometrial cancer, sponsored by Tongji Hospital. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
mazdutide
03
Conditions
Atypical endometrial hyperplasia (AEH)endometrioid endometrial cancer
Beyond the preview
Go deeper on NCT07781150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07781150.